Amneal Pharmaceuticals Inc (NYSE:AMRX)

4.96
BATS BZX Real-Time Price
As of 12:33pm ET
 +0.01 / +0.20%
Today’s Change
3.45
Today|||52-Week Range
7.45
+8.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.4B

Company Description

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.

Contact Information

Amneal Pharmaceuticals, Inc.
400 Crossing Boulevard
Bridgewater New Jersey 08807
P:(908) 947-3120
Investor Relations:
(908) 280-6086

Employees

Shareholders

Individual stakeholders38.32%
Mutual fund holders28.57%
Other institutional15.59%

Top Executives

Chintu PatelCo-Chief Executive Officer & Director
Chirag K. PatelPresident & Co-Chief Executive Officer & Director
Andrew S. BoyerExecutive Vice President-Commercial Operations
Anastasios G. KonidarisChief Financial Officer & Senior Vice President
Nikita ShahChief Human Resources Officer & Senior VP